# SELLAS Life Sciences Group, Inc.: Form 8-K, filed May 13, 2025

- Company: [SELLAS Life Sciences Group, Inc.](/companies/sls.md) (CIK 1390478)
- Form: 8-K
- Filed: 2025-05-13
- Accepted by EDGAR: May 13, 2025, 16:07 ET
- Period: 2025-05-13
- Accession: 0001390478-25-000009
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1390478/000139047825000009/sls-20250513.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1390478/000139047825000009/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1390478/000139047825000009/sls-20250513.htm

Filed May 13, 2025.
Source: SEC EDGAR, the filing index for accession 0001390478-25-000009. Last ingested by Listed: Nov 13, 2026, 15:18 ET. No prices; not investment advice.
